OVARIAN CANCER and US

An ovarian cancer blog which includes quality resource materials: education, research, social networking, genetics and (some) healthcare politics.

“Not everything that can be counted counts and not everything that counts can be counted.”
Albert Einstein

Special items: Ovarian Cancer and Us blog best viewed in Firefox

▼
Showing posts with label GOG 172. Show all posts
Showing posts with label GOG 172. Show all posts
Thursday, May 17, 2012

paywalled - Gynecologic Oncology - Progression-free and overall survival of a modified outpatient regimen of primary intravenous/intraperitoneal paclitaxel and intraperitoneal cisplatin in ovarian, fallopian tube, and primary peritoneal cancer

›
ScienceDirect.com - Gynecologic Oncology - Progression-free and overall survival of a modified outpatient regimen of primary intravenous/int...
Tuesday, March 27, 2012

abstract: Progression-free and overall survival of a modified outpatient regimen of primary intravenous/intraperitoneal paclitaxel and intraperitoneal cisplatin in ovarian, fallopian tube, and primary peritoneal cancer

›
Progression-free and overall survival of a modified outpatient regime... [Gynecol Oncol. 2012] - PubMed - NCBI Abstract OBJECTIVE: G...
›
Home
View web version

Sandi Pniauskas Ovarian Cancer and Us

OvarianCancerandUs
View my complete profile
Powered by Blogger.